Safety and Efficacy of Switching Injected Peptide Long-Acting Somatostatin Receptor Ligands to Once Daily Oral Paltusotine: ACROBAT Edge Phase 2 Study

Patients with acromegaly not cured by surgery are often initially treated with injected peptide long-acting somatostatin receptor ligands (SRLs). Non-peptide small molecules can also activate the somatostatin receptor and do so with a high degree of precision for the target therapeutic receptor subt...

Descripción completa

Detalles Bibliográficos
Autores principales: Gadelha, Monica R, Gordon, Murray B, Doknic, Mirjana, Mezősi, Emese, Tóth, Miklós, Randeva, Harpal, Marmon, Tonya, Luo, Rosa, Monahan, Michael, Madan, Ajay, Ferrara-Cook, Christine, Struthers, Scott, Krasner, Alan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Neuroendocrinology and Pituitary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090738/
http://dx.doi.org/10.1210/jendso/bvab048.1073

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090738/
http://dx.doi.org/10.1210/jendso/bvab048.1073

Ejemplares similares